Medicare Enrolled
Dr. Jennifer McVige, M.D.
Neurology · Amherst, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McVige from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McVige?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McVige
Dr. Jennifer McVige is a neurology specialist in Amherst, NY, with 16 years of NPI registration. Based on federal Medicare data, Dr. McVige performed 3,268 Medicare services across 211 unique beneficiaries.
Between the years covered by Open Payments, Dr. McVige received a total of $951,787 from 80 pharmaceutical and/or device companies across 2485 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McVige is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 15% volume in NY
$951,787 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,268
Medicare services
Top 15% in NY for neurology
211
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~204 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 2,900 | $38 | $65 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
61 | $0 | $6 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
51 | $14 | $53 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
47 | $47 | $125 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
42 | $94 | $220 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
42 | $89 | $150 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
36 | $11 | $34 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
32 | $130 | $200 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
25 | $146 | $607 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
19 | $22 | $53 |
| 3D radiographic procedure with computerized image postprocessing A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data. |
13 | $59 | $185 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.7% high complexity
90.6% medium
2.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$951,787
Total received (2018-2024)
Avg $135,970/year across 7 years
Top 1% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
2,485
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$787,151 (82.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$148,776 (15.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,861 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$86,735
2023
$103,750
2022
$139,230
2021
$168,186
2020
$225,720
2019
$137,874
2018
$90,293
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$64,112
Neurelis, Inc.
$6,920
Axsome Therapeutics, Inc.
$4,375
UCB, Inc.
$4,299
Teva Pharmaceuticals USA, Inc.
$1,932
Otsuka America Pharmaceutical, Inc.
$1,405
MDD US Operations, LLC
$850
Tonix Medicines, Inc.
$603
PFIZER INC.
$529
Lilly USA, LLC
$300
Pyros Pharmaceuticals, Inc.
$233
Lundbeck LLC
$220
SK Life Science, Inc.
$172
LivaNova USA, Inc.
$108
CATALYST PHARMACEUTICALS, INC.
$107
JAZZ PHARMACEUTICALS INC.
$101
SCILEX PHARMACEUTICALS INC.
$74
Biogen, Inc.
$69
ACADIA Pharmaceuticals Inc
$65
Currax Pharmaceuticals LLC
$46
Ipsen Biopharmaceuticals, Inc
$43
Octapharma USA, Inc.
$40
Neurocrine Biosciences, Inc.
$28
GE HEALTHCARE
$28
Mirum Pharmaceuticals, Inc.
$23
Eisai Inc.
$20
Alnylam Pharmaceuticals Inc.
$19
Amneal Pharmaceuticals LLC
$14
Top 3 companies account for 86.9% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$174,882
Allergan, Inc.
$172,887
Amgen Inc.
$153,508
Teva Pharmaceuticals USA, Inc.
$97,241
Lilly USA, LLC
$67,429
AbbVie Inc.
$45,729
Biohaven Pharmaceuticals, Inc.
$33,668
Neurelis, Inc.
$30,974
Biohaven Pharmaceutical Holding Company Ltd.
$30,322
Avanir Pharmaceuticals, Inc.
$29,743
Allergan Inc.
$28,092
Otsuka America Pharmaceutical, Inc.
$20,925
IMPEL PHARMACEUTICALS INC.
$14,706
Lundbeck LLC
$9,973
Promius Pharma LLC
$6,698
Novartis Pharmaceuticals Corporation
$6,294
Eli Lilly and Company
$5,842
UCB, Inc.
$5,594
Axsome Therapeutics, Inc.
$4,375
H. Lundbeck A S
$2,550
MDD US Operations, LLC
$1,033
PFIZER INC.
$965
Biogen, Inc.
$712
SK Life Science, Inc.
$651
Supernus Pharmaceuticals, Inc.
$638
Tonix Medicines, Inc.
$603
Currax Pharmaceuticals LLC
$556
LivaNova USA, Inc.
$508
Assertio Therapeutics, Inc.
$382
Sunovion Pharmaceuticals Inc.
$361
ACADIA Pharmaceuticals Inc
$314
Pyros Pharmaceuticals, Inc.
$233
Eisai Inc.
$230
JAZZ PHARMACEUTICALS INC.
$211
TONIX PHARMACEUTICALS, INC.
$198
Upsher-Smith Laboratories LLC
$178
UPSHER-SMITH LABORATORIES LLC
$166
Collegium Pharmaceutical, Inc.
$155
GE HEALTHCARE
$139
ASSERTIO THERAPEUTICS, Inc.
$134
Egalet US Inc
$127
Amneal Pharmaceuticals LLC
$127
GENZYME CORPORATION
$118
Greenwich Biosciences, Inc.
$109
CATALYST PHARMACEUTICALS, INC.
$107
NeuroPace, Inc.
$99
Alexion Pharmaceuticals, Inc.
$90
GE HealthCare
$90
Pernix Therapeutics Holdings, Inc.
$80
Ipsen Biopharmaceuticals, Inc
$78
Abbott Laboratories
$75
SCILEX PHARMACEUTICALS INC.
$74
ARBOR PHARMACEUTICALS, INC.
$69
Harmony Biosciences LLC
$65
Octapharma USA, Inc.
$58
Neurocrine Biosciences, Inc.
$51
Janssen Pharmaceuticals, Inc
$47
Xeris Pharmaceuticals, Inc.
$42
TerSera Therapeutics LLC
$37
Dr.Reddy's Laboratories,Inc.
$37
NOBELPHARMA AMERICA, LLC
$36
Boston Scientific Corporation
$30
Grifols USA, LLC
$27
MITSUBISHI TANABE PHARMA AMERICA, INC.
$26
Adamas Pharmaceuticals, Inc.
$24
PTC Therapeutics, Inc.
$24
Catalyst Pharmaceuticals, Inc.
$24
Mirum Pharmaceuticals, Inc.
$23
Scilex Pharmaceuticals Inc.
$22
Sarepta Therapeutics, Inc.
$21
Acorda Therapeutics, Inc
$21
Alnylam Pharmaceuticals Inc.
$19
Novocure Inc.
$16
Mallinckrodt LLC
$15
Shire North American Group Inc
$15
Vertical Pharmaceuticals, LLC
$14
CSL Behring
$14
E.R. Squibb & Sons, L.L.C.
$13
Almatica Pharma LLC
$12
Sumitomo Pharma America, Inc.
$7
Top 3 companies account for 52.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · AGAMREE · AIMOVIG · AJOVY · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · BOTOX · BOTOX - NEUROLOGY · BOTOX COSMETIC · BOTOX THERAPEUTIC · Briviact · CAMBIA · COMIRNATY · CONTRAVE · Cambia · Cholbam · DAYBUE · DUOPA · DYSPORT · Dysport · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMFLAZA · EMGALITY · EPIDIOLEX · ERGOMAR · Epidiolex · Exondys 51 · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Gralise · HYFTOR · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KEVEYIS · KOSELUGO · LUMIZYME · LYVISPAH · Leqembi · MAYZENT · METHYLPHENIDATE 72 · NAPRELAN · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · ONZETRA · ONZETRA XSAIL · ONZETRA Xsail · OXTELLAR XR · Oncology · PANZYGA · PAXLOVID · PRIALT · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · REYVOW · RNS System · RYTARY · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · STRENSIQ · SUNOSI · Soliris · Spinraza · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREXIMET · TROKENDI XR · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · VALTOCO · VIGPODER · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VYEPTI · VYVANSE · Vimpat · WAKIX · WATCHMAN Access System · Wakix · XCOPRI · XYWAV · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in NY.
Geographic Context
Neurologists within 10 mi
73
Per 100K population
7.7
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McVige is a mixed practice specialist, with above-average Medicare volume (top 15% in NY), with speaking/promotional industry engagement in the top 1% of NY peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McVige experienced with injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg?
Based on Medicare claims data, Dr. McVige performed 2,900 injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McVige receive payments from pharmaceutical companies?
Yes. Dr. McVige received a total of $951,787 from 80 companies across 2,485 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McVige's costs compare to other neurologists in Amherst?
Dr. McVige's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McVige) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Amherst
Browse neurologists in Amherst ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology